TNC and pancreatic neoplasm: A tumor-specific large TN-C isoform was shown to confer gemcitabine resistance in pancreatic cancer cells by the canonical phosphatidylinositol 3-kinase/AKT/NF-κB signaling pathway by its interaction with Annexin2 (135).